-
-
-
Jakarta, Indonesia
Internal Medicine
Internal Medicine
-
Post By -
Published
February 2026
Precision Diabetology: Moving Beyond “Type 1 vs Type 2”
As genotyping and phenotyping improve, diabetes classification is becoming more nuanced than a simple binary. Precision approaches aim to match treatment strategy to underlying biology and risk, rather than relying on broad labels alone.
GLP-1 Agonists: Benefit, Trade-offs, and Monitoring
GLP-1 therapies have changed obesity and diabetes care. Alongside efficacy, clinicians and patients still need to understand tolerability (especially GI effects), dosing strategy, and safety monitoring.
The “second act” conversation explores benefits beyond weight—metabolic and cardiovascular impacts—while keeping realistic expectations and follow-up.
Kidneys and Hypertension: Why the Silo is Breaking
Blood pressure and kidney function influence each other. A modern integrated approach reduces fragmentation, aligning risk targets, labs, and medication choices across specialties.
Understanding Hemodialysis: A Beginner-Friendly Overview
When chronic kidney disease progresses, hemodialysis supports essential filtration and fluid balance. Patient education and practical planning can reduce anxiety and improve adherence.
One Diagnosis, Many Diseases: The Case for Precision Diabetology
How molecular genotyping and polygenic risk scores are dismantling the Type 1 versus Type 2 binary and ushering in a new era of personalized diabetes care
Beyond the Scale: GLP-1 Receptor Agonists and the New Frontier of Cardio-Renal-Metabolic Medicine
How a single drug class is rewriting the treatment paradigm for heart failure, sleep apnea, and chronic kidney disease
